PremiumRatingsPrivia Health Group’s Strong Performance and Strategic Expansion Drive Positive Outlook Privia Health Reports Strong Q1 2025 Results Privia Health Group: Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating PremiumThe FlyMCOs’ ‘mixed messages’ creating volatility in value-based care, says Truist Privia Health price target raised to $26 from $24 at Baird Privia Health price target lowered to $28 from $30 at Truist PremiumThe FlyPrivia Health price target raised to $29 from $26 at Citizens JMP Privia Health Group: Strong Financial Performance and Strategic Positioning Justify Buy Rating and Increased Price Target Privia Health price target raised to $40 from $25 at Piper Sandler